Noticias de AZN

Noticias del mercado

Últimas noticias sobre AZN — 242 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AZN ✕ 242 resultados
20/03/2026 AZN_US — Stock Titan
AstraZeneca (AZN) admits 45,750 new employee scheme shares to LSE
19/03/2026 AZN_US — Stock Titan
AstraZeneca (AZN) officer Mani Sharma details share and award holdings
17/03/2026 AZN_US — DirectorsTalk Interviews
AstraZeneca PLC (AZN) Stock Analysis: Navigating a 1.86% Potential Upside Amidst Strong Analyst Ratings
16/03/2026 AZN_US — Yahoo Finance
Guggenheim Lifts PT on AstraZeneca PLC (AZN) to 16,000 GBp From 15,500 GBp
16/03/2026 AZN_US — AstraZeneca
Imfinzi approved in the EU as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
15/03/2026 AZN_US — Yahoo Finance
AstraZeneca PLC (AZN) Secures US Priority Review For Candidate Breast Cancer Treatment
15/03/2026 AZN_US — Insider Monkey
AstraZeneca PLC (AZN) Secures US Priority Review For Candidate Breast Cancer Treatment
11/03/2026 AZN_US — Yahoo Finance
Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN)
10/03/2026 AZN_US — AstraZeneca
Notice of Annual General Meeting
09/03/2026 AZN_US — DirectorsTalk Interviews
AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential With A 22.84% ROE
06/03/2026 AZN_US — Stock Titan
AstraZeneca (NYSE: AZN) awards deferred bonus shares to leaders
02/03/2026 AZN_US — DirectorsTalk Interviews
AstraZeneca PLC (AZN.L) Stock Report: Analyzing a Healthcare Powerhouse with a $241 Billion Market Cap
28/02/2026 AZN_US — MarketBeat
Harvest Portfolios Group Inc. Sells 20,219 Shares of AstraZeneca PLC $AZN
27/02/2026 AZN_US — Statista
AstraZeneca revenue by therapeutic area 2022-2025
27/02/2026 AZN_US — Statista
AstraZeneca R&D expenditure as revenue share 2006-2025
26/02/2026 AZN_US — Statista
AstraZeneca revenue 2022-2025, by region
24/02/2026 AZN_US — Reuters
AstraZeneca boosts CEO Soriot's pay to about $24 million for 2025
19/02/2026 AZN_US — Yahoo Finance
Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
19/02/2026 AZN_US — Finviz ES ← EN
Por qué AstraZeneca PLC (AZN) es una de las mejores acciones de inmunoterapia para comprar según los fondos de cobertura
17/02/2026 AZN_US — Fool UK ES ← EN
Por debajo de £151, he aquí por qué el precio de las acciones de AstraZeneca me parece una ganga por debajo de £228,62 después de los sólidos resultados de 2025

Página 12 de 13

keyboard_arrow_up